Đang chuẩn bị liên kết để tải về tài liệu:
TACE versus TACE+entecavir versus TACE+tenofovir in the treatment of HBV associated hepatocellular carcinoma

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

At present, there are a variety of antiviral drugs for HBV in clinical practice, but there is no standard scheme for transcatheter arterial chemoembolization(TACE) combined with antiviral drugs. The aim of this study was to investigate whether TACE must be combined with antiviral therapy in patients of HBV-related hepatocellular carcinoma(HCC). |

TÀI LIỆU LIÊN QUAN

TACE versus TACE+entecavir versus TACE+tenofovir in the treatment of HBV associated hepatocellular carcinoma

Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): A randomized controlled trial

Efficacy and safety analysis of TACE+Donafenib+Toripalimab versus TACE+Sorafenib in the treatment of unresectable hepatocellular carcinoma: A retrospective study

Efficacy of CalliSpheres® microspheres versus conventional transarterial chemoembolization in the treatment of refractory colorectal cancer liver metastasis